FEATURED PRODUCT:  Interpretation of FDA's (QSR) With QSIT references

Example frontpage imageA complete compendium to FDA's Quality System Regulation (QSR) with relative references to FDA's Quality System Inspection Technique (QSIT). Now ONLY $99 (limited time)


Developing policies and procedures
Preparing for FDA audits
Responding to 483 Observations and Warning Letters
Conducting Internal Audits or determining Gap Analysis
 

 

 

Search This Site

 

 

 FDA Regulations say a Component or Accessory

to a Medical Device is a Medical Device

 

This can be a difficult part of the regulation to fully grasp and apply. Mainly because there are a lot of factors that add to the complexity of the issue.

The medical device definition provided by the FDA is useful when distinguishing differences between products such as pharmaceuticals, however falls short of defining the subtle inferences of components and accessories on the overall device.

In the US the FDA defines “Medical Device” as:

"an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is:

recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of it's primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes."



By US law, any manufactured good that is a component of or an accessory to a medical device, is in itself - a medical device. FDA rules state that unless separately classified, a component, parts or accessory to a medical device is regulated in the same way as its parent device.

Products that are not sold with a medical function, but that are incidentally used for a medical purpose, are legally general purpose articles and are exempt from all requirements of the Act except for the prohibitions against adulteration and misbranding. Products which are components of or accessories to a medical device are normally regulated in the same way as the "parent" device. For example, if the parent device is subject to GMPs and premarket notification, the normal presumption is for an accessory to be subject to the same requirements, even if marketed separately2. Furthermore, the manufacturer of a device is responsible for assuring that the ultimate medical device, including all components, complies with the regulations.



Safety and Effectiveness: Dealing with Component Suppliers

The medical device manufacturer is responsible for the safety and effectiveness of all components, including any general-purpose articles incorporated within the device.2

Whether by 100% component inspection or by approving the component supplier, the ultimate medical device manufacturer is responsible for ensuring that the finished product is safe and effective.



Still don’t know Whether your product is a medical device?

Device evaluation and classification activities (Section 513(g)) are carried out by ODE, the Office of Compliance (OC) is bestowed with the responsibility answering inquiries regarding whether or not a particular product is a medical device and thus subject to Center regulatory authority (device determination). If you have doubt as to whether your product is considered a medical device, the best thing to do is to ask the FDA. You can do so at the following locations:



For products regulated by CDRH, requests for classification information under section 513(g) of the act should be submitted to:

513(g) Coordinator,

Food and Drug Administration,

Center for Devices and Radiological Health,

510(k) Document Mail Center (HFZ-401),

9200 Corporate Boulevard, Rockville, MD 20850.



For products regulated by CBER, 513(g) requests should be submitted to:



CBER Ombudsman,

Center for Biologics Evaluations and Research,

Suite 200 North, HFM-4,

1401 Rockville Pike, Rockville, MD 20852-1448.



References:

Guidance for FDA Reviewers and Industry Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices


Telemedicine Related Activities Center for Devices and Radiological Health Food and Drug Administration 11 July 1996
 

 

Site Map »

Media package available for advertisers looking to advertise on this site.